Sandoz Launches High-Concentration Adalimumab In Europe

Plans To ‘Progressively’ Roll Out 100mg/ml Version Of Hyrimoz Biosimilar To Humira

 
• By Dave Wallace
  
High low 3D words
Sandoz will be offering a 100mg/ml high-concentration formulation of Hyrimoz alongside the existing 50mg/ml low-concentration version • Source: Shutterstock

More from Biosimilars

More from Products